" class="no-js "lang="en-US"> John Lee - Medtech Alert
Monday, August 04, 2025
John Lee

John Lee

About John Lee

Accomplished CAR-T immunobiologist with ~ 20 years of cancer cell biology expertise spanning small
and large molecules, as well as cell-based therapeutics. An independent thinker with documented
success creating solutions from problems by bridging the gap between nascent ideas and downstream
deliverables. A creative scientist and proven leader with excellent communication skills who is highly
committed to delivering best-in-class therapeutics to patients in need.

Technical Expertise: Cancer cell biology & cellular therapeutics including CAR-T & TCR-T, Gene-editing platforms (CRISPR, TALEN), Drug discovery & development, HTS design & optimization, Signal transduction pathways, 3D-cell culture models, Target identification & validation, Viral delivery platforms, Nanoparticle-based gene delivery

Related Story

Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World

June 15 2022

The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced today the […]